MAPT and Alzheimer disease: In more than 80% of AD patients the most consistent finding protein is microtubule associated protein i.e. tau in cerebrospinal fluid (CSF) which has direct contact with brain, where the change/modification in the protein levels can be monitored biochemically (Lewczuk et al., 2004).